Correlation Between Cue Biopharma and Conduit Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Conduit Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Conduit Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Conduit Pharmaceuticals, you can compare the effects of market volatilities on Cue Biopharma and Conduit Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Conduit Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Conduit Pharmaceuticals.
Diversification Opportunities for Cue Biopharma and Conduit Pharmaceuticals
-0.72 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Cue and Conduit is -0.72. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Conduit Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Conduit Pharmaceuticals and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Conduit Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Conduit Pharmaceuticals has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Conduit Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cue Biopharma and Conduit Pharmaceuticals
Considering the 90-day investment horizon Cue Biopharma is expected to generate 325.76 times less return on investment than Conduit Pharmaceuticals. But when comparing it to its historical volatility, Cue Biopharma is 6.99 times less risky than Conduit Pharmaceuticals. It trades about 0.0 of its potential returns per unit of risk. Conduit Pharmaceuticals is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest 14.00 in Conduit Pharmaceuticals on August 31, 2024 and sell it today you would lose (12.45) from holding Conduit Pharmaceuticals or give up 88.93% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 34.14% |
| Values | Daily Returns |
Cue Biopharma vs. Conduit Pharmaceuticals
Performance |
| Timeline |
| Cue Biopharma |
| Conduit Pharmaceuticals |
Cue Biopharma and Conduit Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Conduit Pharmaceuticals
The main advantage of trading using opposite Cue Biopharma and Conduit Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Conduit Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Conduit Pharmaceuticals will offset losses from the drop in Conduit Pharmaceuticals' long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Eliem Therapeutics |
| Conduit Pharmaceuticals vs. Cue Biopharma | Conduit Pharmaceuticals vs. Tff Pharmaceuticals | Conduit Pharmaceuticals vs. Eliem Therapeutics | Conduit Pharmaceuticals vs. Inhibrx |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |